Generali Investments Management’s Biogen BIIB Stock Holding History

Generali Investments Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Buy	7,437 +325	+5%	+$62.2K	0.35%	58
2026 Q1	$1.3M	Sell	7,112 -3,862	-35%	-$712K	0.3%	70
2025 Q4	$1.93M	Buy	10,974 +1,004	+10%	+$164K	0.38%	53
2025 Q3	$1.4M	Buy	9,970 +8,008	+408%	+$1.08M	0.29%	71
2025 Q2	$246K	Hold	1,962	–	–	0.06%	125
2025 Q1	$268K	Sell	1,962 -716	-27%	-$102K	0.08%	110
2024 Q4	$410K	Buy	+2,678	New	+$452K	0.11%	99

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

NGM

North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

Generali Investments Management's BIIB Position: Q2 2026 in Review

Generali Investments Management increased its Biogen (BIIB) stake by 4.6% in Q2 2026, buying an estimated $62.2K and bringing the position to 7,437 shares worth $1.61M. The position accounts for 0.35% of the portfolio, ranked #58.

Generali Investments Management first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.93M in Q4 2025. 228 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Generali Investments Management held 7,437 shares of Biogen worth $1.61M as of Q2 2026.
Generali Investments Management bought 325 Biogen shares in Q2 2026, an estimated $62.2K.
Biogen made up 0.35% of Generali Investments Management's portfolio in Q2 2026, its #58 holding.
Generali Investments Management first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
Generali Investments Management's Biogen position peaked at $1.93M in Q4 2025.
228 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.